Metabolic Syndrome and Alopecia: A Case-Control Study
April 2012
in “
Journal of the American Academy of Dermatology
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide → 
Studysummary This study found that psoriasis patients had a significantly higher prevalence of autoimmune diseases and other comorbidities compared to those without psoriasis.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study titled "Metabolic syndrome and alopecia: A case-control study" aimed to quantify the presence of metabolic syndrome factors in patients with different types of alopecia compared to healthy controls. The study included 60 alopecia patients, split evenly between those with alopecia areata (AA) and androgenetic alopecia (AGA), and 60 matched control subjects by age and gender. The presence of metabolic risk factors such as hyperglycemia, hypercholesterolemia, hypertriglyceridemia, low levels of HDL, high abdominal perimeter, and hypertension were assessed, along with smoking status. The results indicated that metabolic risk factors were higher in AGA patients than in AA patients, and AGA patients had higher scores in metabolic parameters compared to control subjects. The study concluded that the cardiovascular risk profiles of patients with AGA and AA are different, suggesting that AGA patients may have a higher risk of cardiovascular issues.
